Coeruleus Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Coeruleus General Information

Description

Developer of a proprietary sublingual spray intended to withdraw next-day residual effects induced by sleep drugs. The company develops self-administered spray formulation incorporating the active ingredient Flumazenil, a generic drug indicated to counteract GABAA related sedatives, currently administered via intravenous injection, enabling patients to treat their sleep disorders without the side effects of sedatives and hypnotic drugs.

Contact Information

Website
www.coeruleus.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Industrial Zone
  • Katzrin 12900
  • Israel
+972
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • Industrial Zone
  • Katzrin 12900
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Coeruleus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 05-May-2021 Completed Out of Business
3. Secondary Transaction - Private 19-May-2020 Completed Startup
2. Early Stage VC 01-Jul-2014 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Coeruleus’s complete valuation and funding history, request access »

Coeruleus Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • Pending

  • Expiring in next 12 mo

Coeruleus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2012221704-A1 Flumazenil complexes, compositions comprising same and uses thereof Active 23-Feb-2011
AU-2012221704-A2 Flumazenil complexes, compositions comprising same and uses thereof Active 23-Feb-2011
AU-2012221704-B2 Flumazenil complexes, compositions comprising same and uses thereof Inactive 23-Feb-2011
CA-2827336-A1 Flumazenil complexes, compositions comprising same and uses thereof Active 23-Feb-2011
EP-2678320-A1 Flumazenil complexes, compositions comprising same and uses thereof Active 23-Feb-2011 A61K31/5517
To view Coeruleus’s complete patent history, request access »

Ready to get started?

Request a free trial

Coeruleus FAQs

  • When was Coeruleus founded?

    Coeruleus was founded in 2009.

  • Where is Coeruleus headquartered?

    Coeruleus is headquartered in Katzrin, Israel.

  • What industry is Coeruleus in?

    Coeruleus’s primary industry is Drug Discovery.

  • Is Coeruleus a private or public company?

    Coeruleus is a Private company.

  • What is Coeruleus’s current revenue?

    The current revenue for Coeruleus is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process